BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 32266805)

  • 21. Surgically Induced Menopause-A Practical Review of Literature.
    Secoșan C; Balint O; Pirtea L; Grigoraș D; Bălulescu L; Ilina R
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31416275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucinous Ovarian Carcinoma.
    Morice P; Gouy S; Leary A
    N Engl J Med; 2019 Mar; 380(13):1256-1266. PubMed ID: 30917260
    [No Abstract]   [Full Text] [Related]  

  • 23. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
    Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
    J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cancer statistics, 2018.
    Torre LA; Trabert B; DeSantis CE; Miller KD; Samimi G; Runowicz CD; Gaudet MM; Jemal A; Siegel RL
    CA Cancer J Clin; 2018 Jul; 68(4):284-296. PubMed ID: 29809280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
    Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK
    Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High grade serous ovarian carcinomas originate in the fallopian tube.
    Labidi-Galy SI; Papp E; Hallberg D; Niknafs N; Adleff V; Noe M; Bhattacharya R; Novak M; Jones S; Phallen J; Hruban CA; Hirsch MS; Lin DI; Schwartz L; Maire CL; Tille JC; Bowden M; Ayhan A; Wood LD; Scharpf RB; Kurman R; Wang TL; Shih IM; Karchin R; Drapkin R; Velculescu VE
    Nat Commun; 2017 Oct; 8(1):1093. PubMed ID: 29061967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
    Klotz DM; Wimberger P
    Arch Gynecol Obstet; 2017 Dec; 296(6):1055-1062. PubMed ID: 28940023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.
    Coburn SB; Bray F; Sherman ME; Trabert B
    Int J Cancer; 2017 Jun; 140(11):2451-2460. PubMed ID: 28257597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and heterogeneity of ovarian cancer.
    Kroeger PT; Drapkin R
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):26-34. PubMed ID: 27898521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian and tubal cancer in Denmark: an update on incidence and survival.
    Gottschau M; Mellemkjaer L; Hannibal CG; Kjaer SK
    Acta Obstet Gynecol Scand; 2016 Oct; 95(10):1181-9. PubMed ID: 27454324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.
    Kurman RJ; Shih IeM
    Am J Pathol; 2016 Apr; 186(4):733-47. PubMed ID: 27012190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
    Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
    J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
    Kehoe S; Hook J; Nankivell M; Jayson GC; Kitchener H; Lopes T; Luesley D; Perren T; Bannoo S; Mascarenhas M; Dobbs S; Essapen S; Twigg J; Herod J; McCluggage G; Parmar M; Swart AM
    Lancet; 2015 Jul; 386(9990):249-57. PubMed ID: 26002111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.
    Bove R; Secor E; Chibnik LB; Barnes LL; Schneider JA; Bennett DA; De Jager PL
    Neurology; 2014 Jan; 82(3):222-9. PubMed ID: 24336141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
    Kurman RJ
    Ann Oncol; 2013 Dec; 24 Suppl 10():x16-21. PubMed ID: 24265397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.
    Chiang YC; Chen CA; Chiang CJ; Hsu TH; Lin MC; You SL; Cheng WF; Lai MS
    J Gynecol Oncol; 2013 Oct; 24(4):342-51. PubMed ID: 24167670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
    Parker WH; Feskanich D; Broder MS; Chang E; Shoupe D; Farquhar CM; Berek JS; Manson JE
    Obstet Gynecol; 2013 Apr; 121(4):709-716. PubMed ID: 23635669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women.
    Svejme O; Ahlborg HG; Nilsson JÅ; Karlsson MK
    BJOG; 2012 Jun; 119(7):810-6. PubMed ID: 22531019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rethinking ovarian cancer: recommendations for improving outcomes.
    Vaughan S; Coward JI; Bast RC; Berchuck A; Berek JS; Brenton JD; Coukos G; Crum CC; Drapkin R; Etemadmoghadam D; Friedlander M; Gabra H; Kaye SB; Lord CJ; Lengyel E; Levine DA; McNeish IA; Menon U; Mills GB; Nephew KP; Oza AM; Sood AK; Stronach EA; Walczak H; Bowtell DD; Balkwill FR
    Nat Rev Cancer; 2011 Sep; 11(10):719-25. PubMed ID: 21941283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.